Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,766 GBX | +2.11% | -0.45% | +21.81% |
May. 31 | US FDA approves Moderna's RSV vaccine, its second marketed product | RE |
May. 30 | Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- GSK Stock
- Revisions GSK plc